Skip to content
  • News
  • Compare
  • Capital
variis
  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Events
  • Funds
  • Press
variis

Longevity intelligence for Singapore and Australia. Sourced and evidence-graded.

Directories

  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Funds
  • Events

Read

  • Archive
  • Capital
  • Compare
  • Glossary

Markets

  • Singapore
  • Australia

variis

  • About
  • Editorial standards
  • AI transparency
  • Corrections
  • Press

Legal

  • Medical disclaimer
  • Privacy policy
  • Terms of service

AI-assisted reporting, human-reviewed. Every claim sourced and graded. Not medical advice.

© 2026 variis · Singapore · Australia

  1. Home
  2. Companies
  3. Telix Pharmaceuticals

Company

Telix Pharmaceuticals

ASX:TLX / NASDAQ:TLX

Radiopharmaceutical theranostics (cancers of ageing).

At a glance

Listing
ASX:TLX / NASDAQ:TLX
Category
ASX listed
Headquarters
Melbourne
Market cap
~US$3.3–3.5B

Thesis

Why it is in this universe

Category
ASX listed
Market
Australia
Recent inflection
+35% YoY; scaling three segments.
Services
None recorded
People tracked
2

Market data

Listing and scale

MetricDetail
ExchangeASX
TickerASX:TLX / NASDAQ:TLX
Secondary listingNASDAQ
Market cap~US$3.3–3.5B
StatusListed and trading
Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.

Get in touch

Contact

Address
Melbourne
Website
No site on file
Phone
No public number published
Email
No public address published

Offering

What it sells today

No commercial services are recorded for this company yet.

People

Who variis tracks here (2)

variis does not publish portraits of named individuals without a licence to do so.

  • LCLindsay CooperChi LongevityNot a registered clinician
  • AMProf Andrea B. MaierGeriatrician; precision geromedicine pioneerPublished self-description only: "Internal Medicine specialist and Geriatrician". No specialty field from any medical register was retrieved.M.D., Ph.D., FRACP (as published on her Science/AAAS author byline). Note: these are published post-nominals, not a register confirmation.Registration published, unchecked

Recent inflection

What moved lately

+35% YoY; scaling three segments.

Common questions

Why does variis track Telix Pharmaceuticals?
Radiopharmaceutical theranostics (cancers of ageing).
Is Telix Pharmaceuticals publicly listed?
Yes. It trades as ASX:ASX:TLX / NASDAQ:TLX. Market capitalisation is in the ~US$3.3–3.5B range, recorded as a dated snapshot rather than a live quote.
Where is Telix Pharmaceuticals based?
Melbourne
Is Telix Pharmaceuticals still trading?
Telix Pharmaceuticals is recorded as actively trading.

Keep reading

Related coverage from the newsroom.

Singapore and Australia · Capital

Singapore and Australia · Capital

Two rounds, one IPO: how Singapore and Australia are funding longevity in 2025 to 2026

Suggest an update

Sources

What this profile is built on

No source is on file for this company yet. Treat everything above as unverified until one is.

Last updated 14 August 2026

Every entity profile on variis is sourced. Not investment advice.